← Back to all signals
RESEARCH PAPER ANALYSIS

[Positive rates and distribution characteristics of pre-existing anti-human-leukocyte-antigen antibodies in patients with different hematological diseases].

AI interpretation is pending for this paper.

Open original publication →
PMID39266500
JournalZhonghua yi xue za zhi
Publication Date2024-09-10
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Clinical data of 1 494 patients with hematological diseases who were scheduled to receive allogeneic hematopoietic stem cell transplantation and received the anti-human-leukocyte-antigen (HLA) antibody test for the first time at the First Affiliated Hospital of Soochow University from 2016 to 2018 was collected to analyze the positive rates and distribution characteristics of different types of pre-existing anti-HLA antibodies in patients with different hematological diseases. Among 1 494 patients with hematological diseases, there were 849 males and 645 females, aged [31 (17, 45)] years, and included 577 cases of acute myeloid leukemia (AML), 373 cases of acute lymphocytic leukemia (ALL), 234 cases of aplastic anemia (AA), 175 cases of myelodysplastic syndrome (MDS), and 135 cases of other diseases. The total positive rate of pre-existing anti-HLA antibodies was 25.1% (375/1 494), among which the positive rates of anti-HLA class Ⅰ, anti-HLA class Ⅱ, and anti-HLA class Ⅰ+Ⅱ antibodies were 11.2% (168/1 494), 4.9% (73/1 494), and 9.0% (134/1 494), respectively.The total positive rates of pre-existing anti-HLA antibodies in patients with MDS、AA、AML、ALL and other diseases were 40.6% (71/175), 30.8% (72/234), 26.2% (151/577), 12.3% (46/373), and 25.9% (35/135), respectively, with statistically significant difference (P<0.001). The positive rates of anti-HLA class Ⅰ, anti-HLA class Ⅱ, and anti-HLA class Ⅰ+Ⅱ antibodies in patients with different hematological diseases showed statistically significant differences (all P<0.001). Given the varying positive rates and distribution characteristics of pre-existing anti-HLA antibodies among patients with different hematological diseases, anti-HLA antibody test should be performed before receiving hematopoietic stem cell transplantation.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Awareness, Accessibility, Authenticity, and Appropriateness: Multilevel Determinants of Research Engagement Among Underrepresented AYA Cancer Survivors. Cancer control : journal of the Moffitt Cancer Center 58.0 2 The Clinical Impact of End-of-Consolidation Measurable Residual Disease in High-Risk Pediatric B-Cell Acute Lymphoblastic Leukemia. Cancer control : journal of the Moffitt Cancer Center 72.4 3 Ischemic stroke as the first manifestation of acute promyelocytic. Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) 60.8 4 CAR-T Versus Non-CAR-T Bridging Strategies Before Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: A Systematic Review. Cureus 87.84 5 p53 and β-Catenin Expression in Gallbladder Carcinoma: Translational Insights for Pediatric Cancer Biology. Asian Pacific journal of cancer prevention : APJCP 64.4 6 Expression of miR-214 in Pediatric Acute Leukemia: Correlations with Leukemia Subtypes, Familial Predisposition, and Hepatitis B Virus Infection. Asian Pacific journal of cancer prevention : APJCP 57.5 7 Relative Survival Rates of Pediatric Patients with Solid Tumours in Khon Kaen, Thailand. Asian Pacific journal of cancer prevention : APJCP 60.02 8 A Cross-Sectional Study of Knowledge, Attitudes, and Perceptions toward HPV Vaccination Among Undergraduate Students Studying in Sarawak, Malaysia. Asian Pacific journal of cancer prevention : APJCP 59.5 9 Breast Cancer-Related Quality of Life among Women Undergoing Treatment: A Hospital-Based Study in Vietnam. Asian Pacific journal of cancer prevention : APJCP 74.84 10 Tobacco Consumption, Early Initiation, and Determinants Among School-Going Adolescents in Ranchi, Jharkhand: A Cross-Sectional Study. Asian Pacific journal of cancer prevention : APJCP 59.0 11 Case 354. Radiology 58.4 12 CAF-derived BHB modulates FXR1-Kbhb and NK-cell lipid metabolism in osteosarcoma. International journal of biological sciences 70.3 13 Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis in the Gulf Cooperation Council: a modified Delphi approach. Frontiers in immunology 63.5 14 Meridian-based traditional Chinese medicine interventions for supportive care in children, adolescents, and young adults with cancer: a systematic review and meta-analysis. Frontiers in pediatrics 85.7 15 Adipose tissue: an overlooked target of medical ionizing radiation and its metabolic consequences. Frontiers in public health 60.6 16 Navigating the immunosuppressive abyss: current hurdles and innovative breakthroughs in neoadjuvant immunotherapy for osteosarcoma. Frontiers in immunology 72.82 17 Subperiosteal lesions: a radiologic spectrum of pathologies and diagnostic considerations. Clinical imaging 55.2 18 Primary Hyperparathyroidism Presenting as a Distal Femur Pathologic Fracture in an Adolescent: A Case Report. JBJS case connector 47.9 19 Femoral Neck System and Cement Augmentation for Temporizing a Pathologic Hip Fracture in Osteosarcoma: A Case Report. JBJS case connector 49.9 20 Sexual dysfunction in women with gestational trophoblastic disease: a cross-sectional study in Recife, Pernambuco, Brazil. PeerJ 59.5 21 Prophylactic thyroidectomy in pediatric multiple endocrine neoplasia type 2: A single-institution case series. International journal of pediatric otorhinolaryngology 56.5 22 Hereditary Predisposition to Acute Myeloid Leukemia: A Novel Germline CEBPA Mutation in a Multigenerational Family. Case reports in hematology 63.5 23 Diagnostic yield of cancer predisposition in a nationwide prospective childhood acute leukemia cohort. Nature communications 62.4 24 Semaglutide for Treating Paediatric Craniopharyngioma-Related Obesity: A Multicentre Case Series. Diabetes, obesity & metabolism 74.2 25 Individualized Patient Education Using Virtual Reality to Prepare Families for Solid Tumor Surgery in Pediatric Oncology. Pediatric blood & cancer 59.9 26 Language, Culture, and Cancer: Qualitative Insights Into Communication Disparities Among Spanish-Speaking Caregivers of Children With Cancer. Pediatric blood & cancer 57.2 27 Analysis of Epstein-Barr Virus and Tumor-Derived Circulating Plasma DNA in Children and Young Adults With Classical Hodgkin Lymphoma in East Africa. Pediatric blood & cancer 61.2 28 Use of dietary supplements and over-the-counter products among adults with a self-reported history of cancer in Poland. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 59.9 29 Machine learning and computational approaches to model therapeutic response and resistance in diffuse midline glioma. Journal of neuro-oncology 66.76 30 Predicting early recurrence of craniopharyngioma using multi-omics radiomic modeling: a retrospective cohort study. Neurosurgical review 67.0 31 Beyond Nerve Hyperexcitability: Potential Implications of Cerebrospinal Fluid CASPR2 Antibodies for Central Pain Processing in Isaacs Syndrome: A Case-Based Systematic Review. Pain and therapy 78.5 32 Definitive surgical outcomes in children with advanced hepatoblastoma (PRETEXT III-IV): A retrospective single-center canadian experience. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 68.5
PATIENT-FRIENDLY SUMMARY

[Positive rates and distribution characteristics of pre-existing anti-human-leukocyte-antigen antibodies in patients with different hematological diseases].

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic